What is the MYCO.NE share price today?

This page shows the latest available Mydecine Innovations Group Inc. (MYCO.NE) price with its change against the prior close. Values are delayed or previous-close, not real-time.

Where is Mydecine Innovations Group Inc. listed?

Mydecine Innovations Group Inc. trades on Cboe Canada under the symbol MYCO.NE, ISIN CA62849F4087.

How large is Mydecine Innovations Group Inc.?

Its market capitalisation is approximately 15.82M CAD, based on the latest available price and share count from our data provider.

Cboe Canada · MYCO.NE · ISIN CA62849F4087

Mydecine Innovations Group Inc.

No trading activity has been reported for this listing since January 13, 2026. It may be delisted, halted or inactive.

0.3500 CAD

January 13, 2026

Mydecine Innovations Group Inc. (MYCO.NE) trades on Cboe Canada and operates in the Drug Manufacturers - Specialty & Generic industry. Its market capitalisation is approximately 15.82M CAD. The company reports around 3 employees. Its ISIN is CA62849F4087. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Key facts

Exchange

Cboe Canada

ISIN

CA62849F4087

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Market cap

21.42M CAD

Employees

Previous close

0.35 CAD

Day range

0.35 – 0.35

52-week range

0.35 – 0.35

Volume

500

50-day average

0.15 CAD

200-day average

0.15 CAD

Asset type

Equity

About Mydecine Innovations Group Inc.

Mydecine Innovations Group Inc. is a biotechnology and life sciences enterprise dedicated to advancing and commercializing therapies for a range of mental health conditions. The company specializes in developing treatments for specific populations, including veterans, emergency medical service providers, frontline workers, and individuals affected by post-traumatic stress disorder. It also operates Mindleap, an online telehealth platform offering mental wellness services and support for psychedelic integration, including aftercare. Furthermore, Mydecine engages in drug discovery, developing nature-derived psychedelic-assisted therapeutics, novel compounds, specific therapy protocols, and unique drug delivery systems. The company also manages a hemp cultivation facility in Pottus, Texas. Strategic collaborations include alliances with Leiden University Medical Center, Royal Ottawa Mental Health Centre, and LeadGen Labs for psychedelic drug development, as well as Applied Pharmaceutical Innovation for drug development and clinical trial programs. Founded in 2013, the company, originally known as NewLeaf Brands Inc., rebranded as Mydecine Innovations Group Inc. in June 2020 and is headquartered in Vancouver, Canada.

Company website

Frequently asked

What is the MYCO.NE share price today?: This page shows the latest available Mydecine Innovations Group Inc. (MYCO.NE) price with its change against the prior close. Values are delayed or previous-close, not real-time.
Where is Mydecine Innovations Group Inc. listed?: Mydecine Innovations Group Inc. trades on Cboe Canada under the symbol MYCO.NE, ISIN CA62849F4087.
How large is Mydecine Innovations Group Inc.?: Its market capitalisation is approximately 15.82M CAD, based on the latest available price and share count from our data provider.

All Mydecine Innovations Group Inc. data comes from exchange and provider feeds for Cboe Canada and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.